These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16027049)

  • 1. Analysis of omeprazole, midazolam and hydroxy-metabolites in plasma using liquid chromatography coupled to tandem mass spectrometry.
    Frerichs VA; Zaranek C; Haas CE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):71-80. PubMed ID: 16027049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes.
    Shimizu M; Uno T; Niioka T; Yaui-Furukori N; Takahata T; Sugawara K; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):241-8. PubMed ID: 16497565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions.
    Zhang W; Han F; Guo P; Zhao H; Lin ZJ; Huang MQ; Bertelsen K; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1169-77. PubMed ID: 20378422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A UHPLC-MS/MS method coupled with liquid-liquid extraction for the quantitation of phenacetin, omeprazole, metoprolol, midazolam and their metabolites in rat plasma and its application to the study of four CYP450 activities.
    Wang Z; Sun W; Lin ZF; Sun R; Huang CK; Ye WJ; Dong YY; Zhang XD; Chen RJ
    J Pharm Biomed Anal; 2019 Jan; 163():204-210. PubMed ID: 30317077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry.
    Kanazawa H; Okada A; Matsushima Y; Yokota H; Okubo S; Mashige F; Nakahara K
    J Chromatogr A; 2002 Mar; 949(1-2):1-9. PubMed ID: 11999727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiral assay of omeprazole and metabolites and its application to a pharmacokinetics related to CYP2C19 genotypes.
    Shiohira H; Yasui-Furukori N; Tateishi T; Uno T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2465-70. PubMed ID: 21783435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid-liquid extraction.
    González HM; Romero EM; Chavez Tde J; Peregrina AA; Quezada V; Hoyo-Vadillo C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(2):459-65. PubMed ID: 12401374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses.
    Cusinato DAC; Filgueira GCO; Rocha A; Cintra MACT; Lanchote VL; Coelho EB
    J Pharm Biomed Anal; 2019 Feb; 164():430-441. PubMed ID: 30445356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of significant effect of grapefruit juice on the pharmacokinetics of lansoprazole and its metabolites in subjects with different CYP2C19 genotypes.
    Uno T; Yasui-Furukori N; Takahata T; Sugawara K; Tateishi T
    J Clin Pharmacol; 2005 Jun; 45(6):690-4. PubMed ID: 15901751
    [No Abstract]   [Full Text] [Related]  

  • 11. Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19.
    Chang M; Tybring G; Dahl ML; Götharson E; Sagar M; Seensalu R; Bertilsson L
    Br J Clin Pharmacol; 1995 May; 39(5):511-8. PubMed ID: 7669487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.
    Link B; Haschke M; Wenk M; Krähenbühl S
    Rapid Commun Mass Spectrom; 2007; 21(9):1531-40. PubMed ID: 17410605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice.
    Tassaneeyakul W; Vannaprasaht S; Yamazoe Y
    Br J Clin Pharmacol; 2000 Feb; 49(2):139-44. PubMed ID: 10671908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear kinetics after high-dose omeprazole caused by saturation of genetically variable CYP2C19.
    Rost KL; Roots I
    Hepatology; 1996 Jun; 23(6):1491-7. PubMed ID: 8675169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of omeprazole and 5'-hydroxyomeprazole in human plasma by liquid chromatography-tandem mass spectrometry.
    Woolf EJ; Matuszewski BK
    J Chromatogr A; 1998 Dec; 828(1-2):229-38. PubMed ID: 9916309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of omeprazole sulfone in a single plasma sample as a probe for CYP3A4.
    Böttiger Y
    Eur J Clin Pharmacol; 2006 Aug; 62(8):621-5. PubMed ID: 16791583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma.
    Huang J; Xu Y; Gao S; Rui L; Guo Q
    Rapid Commun Mass Spectrom; 2005; 19(16):2321-4. PubMed ID: 16021618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration.
    Niioka T; Uno T; Sugimoto K; Sugawara K; Hayakari M; Tateishi T
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1031-8. PubMed ID: 17701405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to Microminipigs.
    Mogi M; Toda A; Iwasaki K; Kusumoto S; Takehara H; Shimizu M; Murayama N; Izumi H; Utoh M; Yamazaki H
    J Toxicol Sci; 2012; 37(6):1157-64. PubMed ID: 23208431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects.
    Tybring G; Böttiger Y; Widén J; Bertilsson L
    Clin Pharmacol Ther; 1997 Aug; 62(2):129-37. PubMed ID: 9284848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.